News & Info - Science and Tech Venture Capital

November 28, 2023

30 Under 30 Venture Capital 2024: Meet The Young Investors Backing Next-Gen Startups From AI To Space Tech

Alex Konrad, Dean Sterling Jones and Alex York

Forbes

Grace Isford

November 21, 2023

Lux Capital Co-Founder: Microsoft Wins the OpenAI Debacle

Ed Ludlow and Caroline Hyde

Bloomberg

Josh Wolfe

October 3, 2023

A More Perfect Union Could Be Good for Workers and Investors

Josh Wolfe

Barron's

Josh Wolfe

August 24, 2023

Generative AI has enhanced cybersecurity weapons, but defenders can still claim a lot of value

Impossible to Inevitable

Yadin Arnon

Generative AI has enhanced cybersecurity weapons, but defenders can still claim a lot of value

Impossible to Inevitable

August 19, 2023

Silicon Valley start-ups revive listing plans as Arm reignites IPO market

George Hammond and Tabby Kinder

Financial Times

Josh Wolfe

August 18, 2023

Lux Q2 2023 Report

LP Letters

Josh Wolfe

Lux Q2 2023 Report

LP Letters

August 17, 2023

If labor unions win, it'll be a tailwind for healthcare services

Morgan Brennan

CNBC

Josh Wolfe

August 10, 2023

Why Bill Gurley & Josh Wolfe Think VCs Won't Deploy All Their Dry Powder Anytime Soon

Eric Newcomer

Josh Wolfe

August 9, 2023

American VCs Fought Back Strict Biden Rules on China Investments. But More May Be Coming

Sarah McBride and Lizette Chapman

Bloomberg

Josh Wolfe

August 2, 2023

Our Investment in Reflex: Building Web Apps in Pure Python

Impossible to Inevitable

Grace Isford

Brandon Reeves

Impossible to Inevitable

July 31, 2023

There’s no better time to be invested in health care stocks

Morgan Brennan and Jon Fortt

CNBC

Deena Shakir

July 31, 2023

How Silicon Valley is helping the Pentagon in the AI arms race

Tabby Kinder

Financial Times

How Silicon Valley is helping the Pentagon in the AI arms race

July 31, 2023

There’s no better time to be invested in health care stocks, says Lux Capital’s Deena Shakir

Morgan Brennan and Jon Fortt

CNBC

Deena Shakir

July 25, 2023

The Endpoints Slack interview: Lux's Josh Wolfe on AI hype, biotech markets, Twitter and more

Andrew Dunn

Endpoints News

Josh Wolfe

July 25, 2023

Less can be More: Sparsity as a Paradigm for LLM Development

Impossible to Inevitable

Siddharth Sharma

Less can be More: Sparsity as a Paradigm for LLM Development

Impossible to Inevitable

July 19, 2023

Databricks wasn’t looking to buy, and MosaicML wasn’t selling. How two CEOs navigated a blockbuster $1.3 billion A.I. deal

Luisa Beltran

Fortune

Shahin Farshchi, PhD

July 17, 2023

An Early Investor in AI Explains How They’re Thinking About the Space Now

Tracy Alloway, Joe Weisenthal and Abraiya Ruffin

Bloomberg

Josh Wolfe

June 30, 2023

IRL’s ex-CEO says he’s ‘shocked’ about the company’s fake users

Alex Heath

The Verge

Shahin Farshchi, PhD

June 26, 2023

Silicon Valley chiefs urge Pentagon procurement overhaul

Tabby Kinder

Financial Times

Silicon Valley chiefs urge Pentagon procurement overhaul

May 25, 2023

VCs are betting on defense tech in 2023

Anne Sraders

Fortune

Josh Wolfe

May 23, 2023

The cost of the global arms race

Callum Williams

The Economist

The cost of the global arms race

April 24, 2023

VCs are scrambling to invest in AI startups in Y Combinator's latest class: 'There's hysteria for a reason'

Stephanie Palazzolo and Madeline Renbarger

Insider

Grace Isford

April 19, 2023

Lux Capital has a new $1.15 billion war chest, and cofounder Josh Wolfe says he’s hunting for the most promising A.I. startups

Anne Sraders

Fortune

Josh Wolfe

April 14, 2023

After raising $1.15B in just 10 weeks, Lux's Josh Wolfe shares his spending plans for his new VC fund

Andrew Dunn and Kyle LaHucik

Endpoints News

Josh Wolfe

April 13, 2023

Keep ‘em coming: Lux Capital bags $1.15B as life sciences funds reel in one round after another in 2023

Kyle LaHucik

Endpoints News

Keep ‘em coming: Lux Capital bags $1.15B as life sciences funds reel in one round after another in 2023

April 13, 2023

VC Lux Capital Raises $1.15 Billion For Science, Deep-Tech Fund

Ed Ludlow

Bloomberg

VC Lux Capital Raises $1.15 Billion For Science, Deep-Tech Fund

April 13, 2023

Lux 8 + Infinite Potential

Impossible to Inevitable

Unum Lux

Lux 8 + Infinite Potential

Impossible to Inevitable

April 5, 2023

Lux Capital’s Josh Wolfe says he isn’t ‘too optimistic’ on Chips Act

Morgan Brennan and Jon Fortt

CNBC

Josh Wolfe

February 22, 2023

Alphabet Layoffs Hit Trash-Sorting Robots

Paresh Dave

Wired

Shahin Farshchi, PhD

February 10, 2023

How the current economic downturn impacts healthcare funding and investor strategy

Anastassia Gliadkovskaya

Fierce Healthcare

Deena Shakir

February 2, 2023

Conversations: 002 - Josh Wolfe

Mr. Exits

Conversations: 002 - Josh Wolfe

January 29, 2023

Modern Meditations: Josh Wolfe

The Generalist

Mario Gabriele

Modern Meditations: Josh Wolfe

January 24, 2023

This Startup Is Using AI to Unearth New Smells

Emily Mullin

Wired

Emily Mullin

This Startup Is Using AI to Unearth New Smells

January 23, 2023

“Navigating Uncertainty” Space VC Webinar Recap

Ryan Duffy

“Navigating Uncertainty” Space VC Webinar Recap

January 20, 2023

Debunking the myths of why venture investors don’t fund diverse startups

Dominic-Madori Davis

TechCrunch

Deena Shakir

January 20, 2023

Investing in Women’s Health

Kristen Bellstrom

Barron's

Deena Shakir

January 11, 2023

Women’s Health Start-Ups Attracting More Interest From Big Pharma, Investors Say

Josh Nathan-Kazis

Barron's

Deena Shakir

January 11, 2023

Finding Health Tech Opportunities

Deirdre Bosa

CNBC

Deena Shakir

January 11, 2023

Deena Shakir, Lux Capital general partner, joins ‘TechCheck’ to discuss her thoughts on health tech stocks and biotech names.

Deirdre Bosa and Jon Fortt

Deena Shakir, Lux Capital general partner, joins ‘TechCheck’ to discuss her thoughts on health tech stocks and biotech names.

January 10, 2023

The top trends in fintech for 2023, according to VCs

Anne Sraders

Grace Isford

Fortune

Grace Isford

January 6, 2023

Josh Wolfe’s War: The Lux Capital Founder Blazes a Controversial Path in Defense Tech

Margaux MacColl

Josh Wolfe’s War: The Lux Capital Founder Blazes a Controversial Path in Defense Tech

December 28, 2022

8 venture investors predict the top trends in fintech for 2023

Anne Sraders

Fortune

Anne Sraders

8 venture investors predict the top trends in fintech for 2023

May 9, 2022

The emoji helping the machine learning community learn faster

Impossible to Inevitable

Danny Crichton

The emoji helping the machine learning community learn faster

Impossible to Inevitable

March 31, 2022

No longer tolerating the decline of American industry

Impossible to Inevitable

Danny Crichton

No longer tolerating the decline of American industry

Impossible to Inevitable

February 24, 2022

On Rebels and Scientists: A Venture Capitalist’s Perspective Ft. Peter Hebert

CXO Podcast

On Rebels and Scientists: A Venture Capitalist’s Perspective Ft. Peter Hebert

February 17, 2022

VCs are warning founders to prep for lower valuations in the coming months, but say there's a silver lining in hiring for young startups

Insider

April Joyner and Alyson Velati

VCs are warning founders to prep for lower valuations in the coming months, but say there's a silver lining in hiring for young startups

February 14, 2022

Welcoming our Newest Investor Grace Isford to Lux Capital

Impossible to Inevitable

Unum Lux

Grace Isford

Impossible to Inevitable

February 2, 2022

Lux Capital's Josh Wolfe on why the buy-the-dip mantra will no longer work

CNBC

Leslie Picker

Lux Capital's Josh Wolfe on why the buy-the-dip mantra will no longer work

January 20, 2022

The robot revolution will be banked

Impossible to Inevitable

Unum Lux

The robot revolution will be banked

Impossible to Inevitable

January 11, 2022

The Renaissance Man of Venture Capital

Michelle Celarier

The Renaissance Man of Venture Capital

No results found. Try resetting the filters to browse the full breadth of our news collection.

Clear Filters

in the news

30 Under 30 Venture Capital 2024: Meet The Young Investors Backing Next-Gen Startups From AI To Space Tech

Lux Capital Co-Founder: Microsoft Wins the OpenAI Debacle

A More Perfect Union Could Be Good for Workers and Investors

Generative AI has enhanced cybersecurity weapons, but defenders can still claim a lot of value

Silicon Valley start-ups revive listing plans as Arm reignites IPO market

Lux Q2 2023 Report

If labor unions win, it'll be a tailwind for healthcare services

Why Bill Gurley & Josh Wolfe Think VCs Won't Deploy All Their Dry Powder Anytime Soon

American VCs Fought Back Strict Biden Rules on China Investments. But More May Be Coming

Our Investment in Reflex: Building Web Apps in Pure Python

There’s no better time to be invested in health care stocks

How Silicon Valley is helping the Pentagon in the AI arms race

There’s no better time to be invested in health care stocks, says Lux Capital’s Deena Shakir

The Endpoints Slack interview: Lux's Josh Wolfe on AI hype, biotech markets, Twitter and more

Less can be More: Sparsity as a Paradigm for LLM Development

Databricks wasn’t looking to buy, and MosaicML wasn’t selling. How two CEOs navigated a blockbuster $1.3 billion A.I. deal

An Early Investor in AI Explains How They’re Thinking About the Space Now

IRL’s ex-CEO says he’s ‘shocked’ about the company’s fake users

Silicon Valley chiefs urge Pentagon procurement overhaul

VCs are betting on defense tech in 2023

The cost of the global arms race

VCs are scrambling to invest in AI startups in Y Combinator's latest class: 'There's hysteria for a reason'

Lux Capital has a new $1.15 billion war chest, and cofounder Josh Wolfe says he’s hunting for the most promising A.I. startups

After raising $1.15B in just 10 weeks, Lux's Josh Wolfe shares his spending plans for his new VC fund

Keep ‘em coming: Lux Capital bags $1.15B as life sciences funds reel in one round after another in 2023

VC Lux Capital Raises $1.15 Billion For Science, Deep-Tech Fund

Lux 8 + Infinite Potential

Lux Capital’s Josh Wolfe says he isn’t ‘too optimistic’ on Chips Act

Alphabet Layoffs Hit Trash-Sorting Robots

How the current economic downturn impacts healthcare funding and investor strategy

Conversations: 002 - Josh Wolfe

Modern Meditations: Josh Wolfe

This Startup Is Using AI to Unearth New Smells

“Navigating Uncertainty” Space VC Webinar Recap

Debunking the myths of why venture investors don’t fund diverse startups

Investing in Women’s Health

Women’s Health Start-Ups Attracting More Interest From Big Pharma, Investors Say

Finding Health Tech Opportunities

Deena Shakir, Lux Capital general partner, joins ‘TechCheck’ to discuss her thoughts on health tech stocks and biotech names.

The top trends in fintech for 2023, according to VCs

Josh Wolfe’s War: The Lux Capital Founder Blazes a Controversial Path in Defense Tech

8 venture investors predict the top trends in fintech for 2023

The emoji helping the machine learning community learn faster

No longer tolerating the decline of American industry

On Rebels and Scientists: A Venture Capitalist’s Perspective Ft. Peter Hebert

VCs are warning founders to prep for lower valuations in the coming months, but say there's a silver lining in hiring for young startups

Welcoming our Newest Investor Grace Isford to Lux Capital

Lux Capital's Josh Wolfe on why the buy-the-dip mantra will no longer work

The robot revolution will be banked

The Renaissance Man of Venture Capital